Literature DB >> 16267284

Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis.

Apoorva Bhatt1, Laurent Kremer, Annie Z Dai, James C Sacchettini, William R Jacobs.   

Abstract

Inhibition or inactivation of InhA, a fatty acid synthase II (FASII) enzyme, leads to mycobacterial cell lysis. To determine whether inactivation of other enzymes of the mycolic acid-synthesizing FASII complex also leads to lysis, we characterized the essentiality of two beta-ketoacyl-acyl carrier protein synthases, KasA and KasB, in Mycobacterium smegmatis. Using specialized transduction for allelic exchange, null kasB mutants, but not kasA mutants, could be generated in Mycobacterium smegmatis, suggesting that unlike kasB, kasA is essential. To confirm the essentiality of kasA, and to detail the molecular events that occur following depletion of KasA, we developed CESTET (conditional expression specialized transduction essentiality test), a genetic tool that combines conditional gene expression and specialized transduction. Using CESTET, we were able to generate conditional null inhA and kasA mutants. We studied the effects of depletion of KasA in M. smegmatis using the former strain as a reference. Depletion of either InhA or KasA led to cell lysis, but with different biochemical and morphological events prior to lysis. While InhA depletion led to the induction of an 80-kDa complex containing both KasA and AcpM, the mycobacterial acyl carrier protein, KasA depletion did not induce the same complex. Depletion of either InhA or KasA led to inhibition of alpha and epoxy mycolate biosynthesis and to accumulation of alpha'-mycolates. Furthermore, scanning electron micrographs revealed that KasA depletion resulted in the cell surface having a "crumpled" appearance, in contrast to the blebs observed on InhA depletion. Thus, our studies support the further exploration of KasA as a target for mycobacterial-drug development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267284      PMCID: PMC1280301          DOI: 10.1128/JB.187.22.7596-7606.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  50 in total

1.  Conditional sigma factor expression, using the inducible acetamidase promoter, reveals that the Mycobacterium tuberculosis sigF gene modulates expression of the 16-kilodalton alpha-crystallin homologue.

Authors:  Y C Manabe; J M Chen; C G Ko; P Chen; W R Bishai
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids.

Authors:  L Wang; R A Slayden; C E Barry; J Liu
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates.

Authors:  J Liu; H Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 4.  Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis.

Authors:  Kuni Takayama; Cindy Wang; Gurdyal S Besra
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis.

Authors:  S Bardarov; J Kriakov; C Carriere; S Yu; C Vaamonde; R A McAdam; B R Bloom; G F Hatfull; W R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis.

Authors:  C Carrière; P F Riska; O Zimhony; J Kriakov; S Bardarov; J Burns; J Chan; W R Jacobs
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance.

Authors:  Asesh Banerjee; Michele Sugantino; James C Sacchettini; William R Jacobs
Journal:  Microbiology (Reading)       Date:  1998-10       Impact factor: 2.777

8.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

9.  Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor.

Authors:  Sabine Ehrt; Xinzheng V Guo; Christopher M Hickey; Marvin Ryou; Mercedes Monteleone; Lee W Riley; Dirk Schnappinger
Journal:  Nucleic Acids Res       Date:  2005-02-01       Impact factor: 16.971

10.  Tetracycline-inducible gene regulation in mycobacteria.

Authors:  Marian C J Blokpoel; Helen N Murphy; Ronan O'Toole; Siouxsie Wiles; Ellen S C Runn; Graham R Stewart; Douglas B Young; Brian D Robertson
Journal:  Nucleic Acids Res       Date:  2005-02-01       Impact factor: 16.971

View more
  52 in total

1.  Molecular dynamics of Mycobacterium tuberculosis KasA: implications for inhibitor and substrate binding and consequences for drug design.

Authors:  Benjamin Schaefer; Caroline Kisker; Christoph A Sotriffer
Journal:  J Comput Aided Mol Des       Date:  2011-11-11       Impact factor: 3.686

2.  Crystal structure of the Mycobacterium tuberculosis transcriptional regulator Rv0302.

Authors:  Tsung-Han Chou; Jared A Delmar; Catherine C Wright; Nitin Kumar; Abhijith Radhakrishnan; Julia K Doh; Meredith H Licon; Jani Reddy Bolla; Hsiang-Ting Lei; Kanagalaghatta R Rajashankar; Chih-Chia Su; Georgiana E Purdy; Edward W Yu
Journal:  Protein Sci       Date:  2015-09-29       Impact factor: 6.725

3.  AccD6, a member of the Fas II locus, is a functional carboxyltransferase subunit of the acyl-coenzyme A carboxylase in Mycobacterium tuberculosis.

Authors:  Jaiyanth Daniel; Tae-Jin Oh; Chang-Muk Lee; Pappachan E Kolattukudy
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

Review 4.  Targeting the formation of the cell wall core of M. tuberculosis.

Authors:  Clifton E Barry; Dean C Crick; Michael R McNeil
Journal:  Infect Disord Drug Targets       Date:  2007-06

5.  Functional role of the PE domain and immunogenicity of the Mycobacterium tuberculosis triacylglycerol hydrolase LipY.

Authors:  Kanhu C Mishra; Chantal de Chastellier; Yeddula Narayana; Pablo Bifani; Alistair K Brown; Gurdyal S Besra; Vishwa M Katoch; Beenu Joshi; Kithiganahalli N Balaji; Laurent Kremer
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

6.  Substrate recognition by β-ketoacyl-ACP synthases.

Authors:  Janine G Borgaro; Andrew Chang; Carl A Machutta; Xujie Zhang; Peter J Tonge
Journal:  Biochemistry       Date:  2011-11-17       Impact factor: 3.162

Review 7.  Natural products, small molecules, and genetics in tuberculosis drug development.

Authors:  Maria-Teresa Gutierrez-Lugo; Carole A Bewley
Journal:  J Med Chem       Date:  2008-04-05       Impact factor: 7.446

8.  Regulated Expression Systems for Mycobacteria and Their Applications.

Authors:  Dirk Schnappinger; Sabine Ehrt
Journal:  Microbiol Spectr       Date:  2014

9.  Slow onset inhibition of bacterial beta-ketoacyl-acyl carrier protein synthases by thiolactomycin.

Authors:  Carl A Machutta; Gopal R Bommineni; Sylvia R Luckner; Kanishk Kapilashrami; Bela Ruzsicska; Carlos Simmerling; Caroline Kisker; Peter J Tonge
Journal:  J Biol Chem       Date:  2009-12-16       Impact factor: 5.157

10.  Crystal structures of Mycobacterium tuberculosis KasA show mode of action within cell wall biosynthesis and its inhibition by thiolactomycin.

Authors:  Sylvia R Luckner; Carl A Machutta; Peter J Tonge; Caroline Kisker
Journal:  Structure       Date:  2009-07-15       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.